Diproponylmorphine, also known as Desomorphine, is a highly addictive synthetic opioid that is derived from morphine. It is categorized as a Schedule I controlled substance in many countries to its high potential for abuse and no accepted medical use.
The synthesis of Diproponylmorphine involves the reaction of thionyl chloride with alpha-chlorocodide, followed by the treatment of 6-dihydrodesoxymorphine with propionic anhydride to produce the final product.
Use of Diproponylmorphine is commonly done by injection, smoking, or snorting. The drug has a rapid onset of action and a short duration of effect, which increases the risk of addiction and overdose.
Adverse effects include:
respiratory depression
sedation, dizziness
nausea, vomiting
constipation.
Tolerance, dependence, and withdrawal symptoms may also occur with long-term use. The use of Diproponylmorphine is highly discouraged in many countries due to its high potential for abuse and serious health complications.
Compared to heroin, Diproponylmorphine is generally considered to be more potent, with up to 10 times the potency of morphine, the parent compound of heroin. The potency of both drugs can vary depending on purity, dosage and tolerance as well as the method of administration. Remember that both of diproponylmorphine and heroin are highly addictive and dangerous substances that can have severe negative impacts on an individual's physical and mental health.